XML 14 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2015
Dec. 31, 2013
Consolidated Statements Of Operations      
Revenues
Operating Expenses      
Research and development $ 574 $ 1,797,045 $ 492,136
General and administrative 183,044 946,613 $ 690,396
Stock-based compensation - general and administrative 470,185 486,271
Total Operating Expenses 653,803 3,229,929 $ 1,182,532
Operating Loss (653,803) (3,229,929) $ (1,182,532)
Other Income (Expense), Net:      
Interest income 555 3,066
Gain on revaluation of derivative warrant liability 8,588 332,095
Interest expense (93,067) (7,500) $ (105,471)
Total Other Income (Expense), Net (83,924) 327,661 (105,471)
Loss before Income Taxes $ (737,727) $ (2,902,268) $ (1,288,003)
Income tax benefit
Net Loss $ (737,727) $ (2,902,268) $ (1,288,003)
Net Loss Per Share - Basic and Diluted $ (0.04) $ (0.09) $ (0.07)
Weighted Average Common Shares Outstanding Basic and diluted 19,322,206 31,835,440 17,757,333